
Dayong Zhou
China
简介:
Department of Vascular Surgery, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital
Chief Physician, Professor, Master Professor, Chief of Division of Vascular Surgery.He graduated from Fudan University School of Medicine with a PhD in 2008, Postdoctoral Fellowship in Cleveland Clinic, USA from 2011 to 2012, and training in several well-known hospitals (including: 2014.7, Chang Gung Hospital, Lin Kou, Taipei, Taiwan; 2018.7- 2019.8, Department of Vascular Surgery, Peking Union Medical College Hospital, Beijing, China).
He has accumulated rich clinical experience in the diagnosis and treatment of aortic, peripheral vascular and various haemorrhage diseases; he is good at the diagnosis and treatment of aortic aneurysm, peripheral arteriosclerosis stenosis/occlusion, lymphatic vessel disease, diabetic foot, varicose veins of the lower limbs and other common diseases, and he has deep theoretical and practical attainments in the diagnosis and treatment of carotid artery stenosis, lymphatic vessel disease (lymphedema), and construction and maintenance of all kinds of difficult haemodialysis pathways.
He is a member of the Third Level Talents of the Fifth "333 Project" of Jiangsu Province, a key young medical talent of Jiangsu Provincial Health Planning Commission, and a member of the "Outstanding Young and Middle-aged Discipline (Academic) Leaders Cultivation Programme" of Nanjing Medical University. He is a member of the Peripheral Vascular Committee of the Chinese Microcirculation Society and vice chairman of the Youth Committee, a member of the Vascular Surgery Branch of the Jiangsu Provincial Physicians' Association and vice chairman of the Carotid Artery Group, a member of the Interventional Medicine Branch of the Jiangsu Provincial Medical Association, and a member of the Interventional Medicine Committee of the Suzhou Medical Association, among others.
She actively participates in clinical research work, presiding over 13 provincial and municipal-level projects (4 in research) and publishing more than 40 papers (16 SCI-recorded papers).